DSIJ Mindshare

Alembic Pharma receives USFDA nod for Desipramine Hydrochloride tablets

Anthony Fernandes 0 766 Article rating: 5.0

On Thursday, Alembic Pharmaceuticals announced that it has received final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Desipramine Hydrochloride tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg & 150 mg.  

IndusInd Bank joins hands with TPCODL to launch fully digital payment network in Odisha

Anthony Fernandes 0 871 Article rating: 5.0

IndusInd Bank announced that it has partnered with TP Central Odisha Distribution Limited (TPCODL), a joint venture between Tata Power and the Government of Odisha to launch a fully digital network for facilitating electricity bill payment across the state.   

RSS
First45679111213Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR